HIMS
Hims Hers Health Inc
$26.98
+14.95%
Price vs Sales Yield
Current Valuation
- Sales Yield
- 25.36%
- P/S
- 3.9x
- P/E Ratio
- 46.0x
- PEG Ratio
- 2.61
P/S Averages
- Median (Fair Value)
- 4.7x
- Industry (Damodaran)
- 5.6x
- 1-Year Avg
- 3.9x
- 3-Year Avg
- 3.4x
- 5-Year Avg
- 3.1x
- Min / Max
- 2.3x / 11.6x
Revenue Growth
- YoY Growth
- 69.3%
- 3-Year CAGR
- 75.8%
- 5-Year CAGR
- 78.0%
Financial Snapshot
- Market Cap
- $5.35B
- Enterprise Value
- $5.89B
- Revenue (TTM)
- $2.35B
- Dividend Yield
- -
Valuation Context
vs 5-Year Average
26%
Above average (potentially overvalued)
Sales Yield
25.36%
High yield
vs Industry (Drugs (Pharmaceutica...)
-31%
Below industry avg
Data Points
751
daily data points